Studies of immunopathogenesis in dengue virus infection. (360G-Wellcome-095541_A_11_Z)

£2,839,596

Dengue virus is transmitted to man following a bite from an infected mosquito. Although most dengue infections are relatively mild, it can lead to the more severe disease, dengue haemorrhagic fever. One of the interesting features of dengue is that there are four different viruses and immunity to one infection does not lead to immunity to the others meaning that secondary infections are common. Patients are more likely to develop symptoms during these secondary infections as opposed to their fir st infection implying some aspect of the immune response drives more severe disease. This projects aims to gain a greater understanding of the immune enhancement of disease and also to research strategies to design better vaccines to dengue.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region South East
Award Date 2011-05-10T00:00:00+00:00
Internal ID 095541/A/11/Z
Planned Dates: End Date 2021-03-31T00:00:00+00:00
Planned Dates: Start Date 2012-10-01T00:00:00+00:00
Amount Awarded 2839596
Financial Year 2010/11
Lead Applicant Prof Gavin Robert Screaton
Grant Programme: Title Investigator Award in Science
Applicant Surname Screaton
Approval Committee Science Interview Panel
Recipient Org: Country United Kingdom
Recipient Org: City Oxford
Has the grant transferred? Yes
Research conducted at multiple locations? Yes
Total amount including partnership funding 2839596

Help shape the next 10 years of GrantNav!

GrantNav is celebrating its 10th anniversary. Take our quick 3-minute survey to tell us how we can make the data work better for you.

Take the Survey